Tirzepatide
SURMOUNT-3
Eli Lilly · Phase 3 · Completed · Enrollment 579
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 72 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 72 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Tirzepatide
Eli Lilly · Phase 3 · Completed · Enrollment 579
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 72 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 72 | n/r | n/r |